Orange County Business Journal

Mallinckrodt Boss Calls Questcor ‘Ideal Strategic Fit’

Says It Can Maximize Value of Questcor Drugs

Anaheim-based Questcor Pharmaceuticals Inc. will help create a “strong, nicely balanced specialty pharmaceutical platform” for Mallinckrodt PLC, according to the latter’s chief executive.

Tease photo

Analyst: Allergan Likely to Stand Alone

Allergan Inc. is likely to remain a standalone company, according to recent report by a veteran analyst.

Tease photo

Analyst: Allergan Likely to Stand Alone

Allergan Inc. is likely to remain a standalone company, according to recent report by a veteran analyst.

Tease photo

Valeant to Hike Allergan Bid

Valeant Pharmaceuticals International Inc. said today that it will put in an “improved offer” to buy Irvine-based Allergan Inc.

Tease photo

Masimo Shares Rise

Shares of Irvine-based Masimo Corp. rose Monday on news that it is cooperating with a federal investigation and has received a grand jury subpoena on documents relating to a pair of its monitors.

Tease photo

Masimo Shares Rise

Shares of Irvine-based Masimo Corp. rose today on news that it is cooperating with a federal investigation and has received a grand jury subpoena on documents relating to a pair of its monitors.

Tease photo

Allergan Board Rejects Valeant Bid

Irvine-based drug maker Allergan Inc. today rejected a hostile $46 billion takeover bid by Valeant Pharmaceuticals International Inc.

Sabra, Ensign Making More Deals for Properties

Out-of-State Buys Part of Continued Expansions

Sabra Healthcare REIT Inc. and Ensign Group Inc. are buying more properties.

Allergan’s Influence

Drug Maker at Center of Hostile Bid Hub of Executive Talent

Allergan Inc., the Irvine-based drug maker that’s currently the target of a hostile takeover attempt, has been a farm team of sorts when it comes to Orange County’s vibrant drug and medical device sectors.

Tease photo

Financial Times: Allergan to Reject Valeant Bid

Irvine-based drug maker Allergan Inc. could reject a hostile $47 billion takeover bid by Valeant Pharmaceuticals International Inc. as early as Monday, according to a report today by the Financial Times.

Tease photo

Valeant, Ackman Want to Change Allergan Board

Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman’s Pershing Square Capital Management LP said Thursday they would team up in an attempt to force changes to the board of Irvine-based drug maker Allergan Inc.

Tease photo

Valeant, Ackman Want to Change Allergan Board

Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman’s Pershing Square Capital Management LP said today they would team up in an attempt to force changes to the board of Irvine-based drug maker Allergan Inc.

Tease photo

Allergan Beats on Q1, Lifts Guidance amid Valeant Bid

Irvine-based Allergan Inc. on Wednesday reported first-quarter profit and revenue that surpassed analysts’ expectations and hiked its full-year guidance.

Tease photo

MemorialCare Teaming With Cedars-Sinai on Investment Fund

Fountain Valley-based MemorialCare Health System said today that it will partner with Cedars-Sinai Health System in Los Angeles to establish Summation Health Ventures.

Tease photo

Sabra to Sell 7 Million Shares of Stock

Sabra Health Care REIT Inc. said Wednesday that it was offering 7 million shares of its common stock priced at $28.35 a share.

Tease photo

Sabra to Sell 7 Million Shares of Stock

Sabra Health Care REIT Inc. said today that it was offering 7 million shares of its common stock priced at $28.35 a share.

Tease photo

MemorialCare Teaming With Cedars-Sinai on Investment Fund

Fountain Valley-based MemorialCare Health System said today that it will partner with Cedars-Sinai Health System in Los Angeles to establish Summation Health Ventures.

Tease photo

Allergan Beats on Q1, Lifts Guidance amid Valeant Bid

Irvine-based Allergan Inc. today reported first-quarter profit and revenue that surpassed analysts’ expectations and hiked its full-year guidance.

Tease photo

Allergan Investor Touts Valeant’s ‘Superior’ Bid in Letter

Irvine-based Allergan Inc. should “make the best possible deal” with Canada’s Valeant Pharmaceuticals International Inc. or identify a “superior transaction with another company,” activist investor Bill Ackman said Monday.

Allergan Investor Touts Valeant’s ‘Superior’ Bid in Letter

Irvine-based Allergan Inc. should “make the best possible deal” with Canada’s Valeant Pharmaceuticals International Inc. or identify a “superior transaction with another company,” activist investor Bill Ackman said today.

Judge Rules Avanir Drug Patents Valid

Aliso Viejo-based Avanir Pharmaceuticals Inc.’s stock shot up midweek after a federal court ruled in its favor in a patent lawsuit against two potential generic competitors.

Figuring Fits for Allergan’s Future

Fast-Growing Product Lineup Key for Would-Be Buyers

The fast-growing and diverse product lineup that has drawn a hostile bid for Allergan Inc. could also be just the thing to attract a “white knight” for the Irvine-based drug maker.

Edwards Chief Confident in Return on New Products

With Approvals, Growth Expected Despite Rival

Irvine-based Edwards Lifesciences Corp.’s chief executive said he thinks new product introductions will bring “some significant uptick” in the market for less-invasive heart valves.”

Streamlined Medical Model Attracts $125M in Funding

HEALTHCARE: Irvine firm works with ill seniors

Irvine-based Alignment Healthcare LLC is emphasizing coordination and management in an effort to cut healthcare costs.

Tease photo

Avanir Surges on Patent Ruling

Aliso Viejo-based Avanir Pharmaceuticals Inc.’s stock shot up on Wednesday after a federal court ruled in its favor in a patent lawsuit against two potential generic competitors.

Tease photo

Avanir Surges on Patent Ruling

Aliso Viejo-based Avanir Pharmaceuticals Inc.’s stock shot up today after a federal court ruled in its favor in a patent lawsuit against two potential generic competitors.

Tease photo

Bloomberg: Allergan Looking at Sale

Irvine-based drug maker Allergan Inc. has contacted Johnson & Johnson and France’s Sanofi SA to see if either company would be interested in buying it, according to a Bloomberg report.

OC Could Become Stem Cell Concentration Down Road

Head of Startup Says Some Interested in Spinoffs

A concentration of stem-cell-related companies may eventually grow out of work at the University of California-Irvine, but one of the institution’s pioneer researchers expects it to take a while to come to fruition.

Stem Cell Deal Puts Manufacturing Might on Keirstead’s Side

HEALTHCARE: Pioneer’s startup to operate here as unit of N.Y. owner

Manufacturing is the key to the vast potential of stem cells.

Analysts Downplay Covidien Aneurysm Devices Recall

Coating Could Come Off, Lead to Stroke or Death

Covidien PLC’s voluntary recall of more than 600 Orange County-manufactured aneurysm devices will be a slight hit on its top line, according to industry watchers.

Tease photo

Allergan Acquires Dermal Filler Candidate

Irvine-based Allergan Inc. acquired a dermal filler candidate from Menlo Park-based incubator TauTona Group.

Tease photo

Allergan Acquires Dermal Filler Candidate

Irvine-based Allergan Inc. said today that it acquired a dermal filler candidate from Menlo Park-based incubator TauTona Group.

Tease photo

California Stem Cell to Be Bought by NeoStem

Irvine-based California Stem Cell Inc. said today that it was being acquired by NeoStem Inc. in a stock and cash deal that potentially could be worth $124 million.

Edwards Gets European Clearance for Heart Valve

Says More Can Get Less Invasive Procedure Now

Irvine-based Edwards Lifesciences Corp.’s run of good news continued this month.

Questcor Expected to Stay After $5.6B Sale

HEALTHCARE: Anaheim company to continue operations as own unit

It appears that the local operations of Questcor Pharmaceuticals Inc. would remain intact in the wake of Mallinckrodt PLC’s $5.6 billion proposed buyout of the Anaheim-based drug maker—the largest deal so far in what’s shaping up to be a busy year for mergers and acquisitions involving Orange County-based companies.

Tease photo

Hoag Extends Obligation on Women’s Health Services

Hoag Memorial Hospital Presbyterian has entered into a voluntary agreement with state Attorney General Kamala Harris’ office to extend its obligation to provide women’s health services.

Regulators Accept Avanir’s New-Drug Application

AVP-825 Drug-Device Combo to Treat Migraines

Aliso Viejo-based Avanir Pharmaceuticals Inc. wrapped up last month in a busy fashion.

Pyott’s Place: Not Big Pharma

CEO: Cash-Pay Lines, Less Bureaucracy Set Allergan Apart

Call Allergan Inc. the biggest publicly traded company in Orange County. Just don’t call it “Big Pharma.”

Edwards Gets Taste of Better Days on Comparison Trial

HEALTHCARE: Shares up 13% this year after rugged 2013

Investors are once again taking a shine to Irvine-based Edwards Lifesciences Corp. after a tough 2013.

Biolase Shareholder in Mood for Fight

HEALTHCARE: East Coast investor nominates 4 to board

Irvine-based medical device maker Biolase Inc. is facing the prospect of a proxy fight with its largest shareholder.

Tease photo

Hoag Extends Obligation on Women’s Health Services

Hoag Memorial Hospital Presbyterian has entered into a voluntary agreement with state Attorney General Kamala Harris’ office to extend its obligation to provide women’s health services.

Questcor Pharmaceuticals Responds to Recent ‘Bear Raid’

Acthar Maker Says Shorts Have Caused Volatility

Questcor Pharmaceuticals Inc., one of Orange County’s more volatile public companies, recently released a lengthy federal filing addressing what it characterized as a “bear raid” by short sellers.

Startup Device Maker Raises $32.5M

Irvine-based Axonics Modulation Technologies Inc. completed a $32.5 million first round of financing.

$32.5 Million for Irvine Device Maker

Irvine-based Axonics Modulation Technologies Inc. said today it completed a $32.5 million first round of financing.

Sonendo Raises $10 Million

Sonendo Inc., a Laguna Hills-based dental device company, closed a $10 million venture debt financing with Alexandria, Va.-based Oxford Finance LLC.

Sonendo Raises $10 Million

Sonendo Inc., a Laguna Hills-based dental device company, closed a $10 million venture debt financing with Alexandria, Va.-based Oxford Finance LLC.

$32.5 Million for Irvine Device Maker

Irvine-based Axonics Modulation Technologies Inc. said today it completed a $32.5 million first round of financing.

UK Device Maker Eyes Offering Here

HEALTHCARE: Lombard’s US operations in Irvine

A British medical device maker that has its U.S. headquarters in Irvine is seeking its fortune in the U.S.

Device Designer to Stay Local Under New Owner

HEALTHCARE: Sees benefit in Illinois company’s size

An Irvine design and engineering firm that develops products for medical device and biotech companies has been sold to a larger competitor.

Allergan Growth Outlook ‘Noteworthy Exception’

Among Best Large-Cap Growth Prospects

Irvine-based Allergan Inc. is offering “a precious commodity” for pharmaceutical investors—growth, according to one analyst.